214 related articles for article (PubMed ID: 22463586)
1. Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.
Li MY; Kong AW; Yuan H; Ma LT; Hsin MK; Wan IY; Underwood MJ; Chen GG
Curr Cancer Drug Targets; 2012 Jul; 12(6):597-606. PubMed ID: 22463586
[TBL] [Abstract][Full Text] [Related]
2. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
3. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer.
Yuan H; Li MY; Ma LT; Hsin MK; Mok TS; Underwood MJ; Chen GG
Thorax; 2010 Apr; 65(4):321-6. PubMed ID: 20388757
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.
Li MY; Hsin MK; Yip J; Mok TS; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Jan; 42(1):113-22. PubMed ID: 19346318
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
Li MY; Yuan HL; Ko FW; Wu B; Long X; Du J; Wu J; Ng CS; Wan IY; Mok TS; Hui DS; Underwood MJ; Chen GG
Cancer; 2015 Sep; 121 Suppl 17():3130-45. PubMed ID: 26331820
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis.
Aoki Y; Maeno T; Aoyagi K; Ueno M; Aoki F; Aoki N; Nakagawa J; Sando Y; Shimizu Y; Suga T; Arai M; Kurabayashi M
Respiration; 2009; 77(3):311-9. PubMed ID: 18974632
[TBL] [Abstract][Full Text] [Related]
7. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.
Yang S; Gong Z; Liu Z; Wei M; Xue L; Vlantis AC; Zhang Y; Chan JY; van Hasselt CA; Zeng X; Qiu S; Tang N; Du J; Wei W; Tong MC; Chen GG
Front Endocrinol (Lausanne); 2021; 12():708248. PubMed ID: 34557159
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.
Da Silva Morais A; Abarca-Quinones J; Horsmans Y; Stärkel P; Leclercq IA
Int J Mol Med; 2007 Jan; 19(1):105-12. PubMed ID: 17143554
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
Takano S; Kubota T; Nishibori H; Hasegawa H; Ishii Y; Nitori N; Ochiai H; Okabayashi K; Kitagawa Y; Watanabe M; Kitajima M
Anticancer Res; 2008; 28(6A):3593-9. PubMed ID: 19189639
[TBL] [Abstract][Full Text] [Related]
11. Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.
Zang C; Wächter M; Liu H; Posch MG; Fenner MH; Stadelmann C; von Deimling A; Possinger K; Black KL; Koeffler HP; Elstner E
J Neurooncol; 2003 Nov; 65(2):107-18. PubMed ID: 14686729
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
Yang Y; Zhao LH; Huang B; Wang RY; Yuan SX; Tao QF; Xu Y; Sun HY; Lin C; Zhou WP
Mol Carcinog; 2015 Dec; 54(12):1584-95. PubMed ID: 25307746
[TBL] [Abstract][Full Text] [Related]
13. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
[TBL] [Abstract][Full Text] [Related]
14. Chronic exposure of lung alveolar epithelial type II cells to tobacco-specific carcinogen NNK results in malignant transformation: a new in vitro lung carcinogenesis model.
Mennecier G; Torres LN; Cogliati B; Sanches DS; Mori CM; Latorre AO; Chaible LM; Mackowiak II; Nagamine MK; Da Silva TC; Fukumasu H; Dagli ML
Mol Carcinog; 2014 May; 53(5):392-402. PubMed ID: 23203541
[TBL] [Abstract][Full Text] [Related]
15. Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats.
Kinouchi T; Kitazato KT; Shimada K; Yagi K; Tada Y; Matsushita N; Sumiyoshi M; Satomi J; Kageji T; Nagahiro S
Stroke; 2012 Feb; 43(2):478-83. PubMed ID: 22076002
[TBL] [Abstract][Full Text] [Related]
16. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
Yamamoto Y; Ono T; Dhar DK; Yamanoi A; Tachibana M; Tanaka T; Nagasue N
J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
Han EJ; Im CN; Park SH; Moon EY; Hong SH
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats.
Guo YT; Leng XS; Li T; Zhao JM; Lin XH
World J Gastroenterol; 2004 Dec; 10(23):3419-23. PubMed ID: 15526359
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis.
Suzuki S; Mori Y; Nagano A; Naiki-Ito A; Kato H; Nagayasu Y; Kobayashi M; Kuno T; Takahashi S
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973395
[TBL] [Abstract][Full Text] [Related]
20. PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway.
Ni J; Zhou LL; Ding L; Zhao X; Cao H; Fan F; Li H; Lou R; Du Y; Dong S; Liu S; Wang Z; Ma R; Wu J; Feng J
Exp Cell Res; 2017 Dec; 361(2):246-256. PubMed ID: 29080795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]